KEY OPINION LEADER DEVELOPMENT
Understanding KOLs’ Communication Preferences and Interests to Better Initiate and Maintain Successful Relationships
Carol Fier, Senior Regional Medical Liaison, Oncology, Scientific Affairs, Global Development, AMGEN
Steve Thuillier, Director of RML Planning and Operations, AMGEN

VALUE OF INTERNAL PARTNERSHIPS
Compliantly Communicating with Cross-Functional Teams to Advance Field Information Dissemination Strategy and Effectiveness
Michael DeGeorge, PharmD, Regional Director, Medical Liaisons, KING PHARMACEUTICALS

DEFINING THE ROLE OF THE MSL
Characterizing the MSL Position in a Time of Industry Shifts to Ensure Continued Value to Internal and External Stakeholders
Elizabeth Kupferer, PhD, Medical Liaison II, BAYER HEALTHCARE

PANEL DISCUSSION
Considering and Responding to the Changing Nature of the KOL Moderator:
Lisa Burke, PhD, MBA, RN, Associate Director, Medical Science Liaison Development, UCB
Panelists:
David R. Rutledge, PharmD, Director, Worldwide Clinical Affairs, ABBOTT
Krystene Woodard, PhamD, National Medical Science Liaison Manager, SHIRE

Plus!
Be sure to attend the preconference workshop on MSL Performance Evaluation, participate in roundtable discussions and join us at a cocktail reception for conference attendees!